potential use for novel and emerging agents in patients with newly-diagnosed/smoldering myeloma
Published 10 years ago • 70 plays • Length 17:40Download video MP4
Download video MP3
Similar videos
-
22:28
case 1: patient with high-risk smoldering myeloma
-
19:45
comy 2016 smouldering myeloma diagnostic criteria: palumbo
-
19:19
smoldering myeloma: who and when to treat?
-
30:45
smoldering multiple myeloma – defining high risk and deciding who to treat
-
21:57
current and emerging novel immunotherapies for myeloma
-
40:06
multiple myeloma: a pathway to better outcomes
-
20:53
novel small molecules in multiple myeloma: update on key results from emerging clinical studies
-
22:15
smoldering myeloma: who and when to treat?
-
29:45
debate: ideal treatment fro smoldering myeloma
-
1:03:18
emerging research in the smoldering myeloma field with dr. kazandjian
-
58:44
treatments available for high risk smoldering myeloma patients
-
0:41
improving risk stratification models for patients with mgus and smoldering myeloma
-
4:12
updating the nccn guidelines for the diagnosis and treatment of mgus and smm
-
7:44
smoldering myeloma: treatment and risk stratification
-
1:47
the potential of early treatment of smm with immunotherapy
-
21:22
multiple myeloma: combination therapy for relapsed/refractory patients
-
24:06
high risk myeloma: how and should it be treated differently?
-
18:29
case 3: elderly patient with newly diagnosed myeloma
-
19:23
emerging immunotherapies in multiple myeloma